A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults
一项首次人体试验的 1/1b 期随机试验,旨在评估呼吸道合胞病毒 (RSV) 病毒样颗粒亚单位疫苗 (IVX-121) 在健康青年和老年人中的安全性和免疫原性。
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2026.2633021
De Coster, Ilse; Leroux-Roels, Isabel; Withanage, Kanchanamala; Suykens, Leen; D'Onofrio, Valentino; Leroux-Roels, Geert; van Damme, Pierre; Ciarlet, Max; Adams, Elizabeth M; Rida, Wasima; Wen, Judy; MacDonald, Margaret; Price, Jennifer; Kanesa-Thasan, Niranjan